Activated B cells mediate efficient expansion of rare antigen-specific T cells

Hum Immunol. 2007 Feb;68(2):75-85. doi: 10.1016/j.humimm.2006.12.004. Epub 2007 Jan 8.

Abstract

Potent professional antigen-presenting cells (APC) are essential tools to activate and expand antigen-specific T cells in vitro for use in adoptive immunotherapy. CD40-activated B cells can be easily generated and propagated from human donors and have been successfully used to generate antigen-specific T-cell cultures. Here we show that CD40-activated B cells strongly and specifically expand rare populations of antigen-specific CD8 T cells, with frequencies of less than 1 in 20,000 CD8 T cells in peripheral blood. We focused on T cells recognizing an epitope from the human papillomavirus 16 (HPV-16) E7 protein. In 6 of 6 healthy donors, epitope-specific CD8+ T cells were found to be "rare" by this criterion, as shown by staining with human leukocyte antigen (HLA)/peptide multimers. Using peptide-loaded CD40-activated B cells, epitope-specific T cells could be selectively expanded in all donors up to 10(6) fold, and the resulting T-cell cultures contained up to 88% specific T cells. These results strongly encourage the use of CD40-stimulated B cells as APCs in immunotherapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigen-Presenting Cells / immunology
  • B-Lymphocytes / immunology*
  • CD40 Antigens / immunology
  • CD8-Positive T-Lymphocytes / immunology*
  • Cells, Cultured
  • Epitopes, T-Lymphocyte / immunology
  • HLA-A2 Antigen / immunology
  • Humans
  • Immunotherapy / methods
  • Lymphocyte Activation
  • Oncogene Proteins, Viral / chemical synthesis
  • Oncogene Proteins, Viral / immunology
  • Papillomavirus E7 Proteins
  • Species Specificity
  • T-Lymphocyte Subsets / immunology

Substances

  • CD40 Antigens
  • Epitopes, T-Lymphocyte
  • HLA-A2 Antigen
  • Oncogene Proteins, Viral
  • Papillomavirus E7 Proteins
  • oncogene protein E7, Human papillomavirus type 16